[HTML][HTML] Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - nature.com
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - ora.ox.ac.uk
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - search.ebscohost.com
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - europepmc.org
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - pubmed.ncbi.nlm.nih.gov
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - search.proquest.com
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
[HTML][HTML] Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - ncbi.nlm.nih.gov
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …
association with poor psychosocial functioning and reduced clinical engagement. There is …
[引用][C] Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
MJ Colwell, H Tagomori, S Chapman, AL Gillespie… - 2022 - europepmc.org
Cognitive impairment is a core feature of major depressive disorder (MDD), broadly
characterised by heterogeneous reductions in executive functioning, learning and memory …
characterised by heterogeneous reductions in executive functioning, learning and memory …